Evaluating the use of targeted axillary dissection and comprehensive physical therapy to reduce the risk of lymphedema in node-positive breast cancer patients

被引：0
|
作者：
Amin, Miral [1 ]
Shah, Karan [1 ]
机构：
[1] Canc Treatment Ctr Amer, Zion, IL 60099 USA
来源：
CANCER RESEARCH | 2020年 / 80卷 / 04期
关键词：
D O I：
10.1158/1538-7445.SABCS19-P1-20-22
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1-20-22
引用
收藏
页数：4
相关论文
共 50 条
  • [41] Axillary Reverse Mapping in Clinically Node-Positive Breast Cancer Patients
    Noguchi, Masakuni
    Inokuchi, Masafumi
    Yokoi-Noguchi, Miki
    Morioka, Emi
    Haba, Yusuke
    Takahashi, Tomoko
    Shioya, Akihiro
    Yamada, Sohsuke
    CANCERS, 2023, 15 (21)
  • [42] Outcomes of sentinel lymph node-positive breast cancer patients after mastectomy with or without axillary lymph node dissection
    Matsumoto, A.
    Umemoto, Y.
    Yoshikawa, M.
    Jinno, H.
    EUROPEAN JOURNAL OF CANCER, 2018, 92 : S71 - S72
  • [43] Targeted axillary dissection reduces residual nodal disease in clinically node-positive breast cancer after neoadjuvant chemotherapy
    Cabioglu, Neslihan
    Karanlik, Hasan
    Yilmaz, Ravza
    Emiroglu, Selman
    Tukenmez, Mustafa
    Bademler, Sueleyman
    Simsek, Duygu Has
    Kantarci, Tarik Recep
    Yirgin, Inci Kizildag
    Bayram, Aysel
    Dursun, Memduh
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2024, 22 (01)
  • [44] Prospective Evaluation of Radar-Localized Reflector-Directed Targeted Axillary Dissection in Node-Positive Breast Cancer Patients after Neoadjuvant Systemic Therapy
    Gallagher, Kristalyn K.
    Iles, Kathleen
    Kuzmiak, Cherie
    Louie, Raphael
    McGuire, Kandace P.
    Ollila, David W.
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2022, 234 (04) : 538 - 545
  • [45] A declining rate of completion axillary dissection in sentinel lymph node-positive breast cancer patients is associated with the use of a multivariate nomogram
    Park, Julia
    Fey, Jane V.
    Naik, Arpana M.
    Borgen, Patrick I.
    Van Zee, Kimberly J.
    Cody, Hiram S., III
    ANNALS OF SURGERY, 2007, 245 (03) : 462 - 468
  • [46] Evaluation of targeted axillary dissection following neoadjuvant therapy for a patient with node-positive breast cancer as initial experience in Ain Shams University Hospitals
    Mohamed, Ahmed M. A.
    Eldin, Mohamed A. H. Mohamed Shehab
    Riad, Aimra M.
    Almoaty, Karim F. A.
    EGYPTIAN JOURNAL OF SURGERY, 2022, 41 (02): : 626 - 633
  • [47] Nodal Upstaging in Sentinel Lymph Node-positive Breast Cancer after Axillary Node Dissection (ALND)
    Laronga, C.
    Johns, C.
    Snow, R.
    Sun, W.
    Fulp, W.
    Kiluk, J. V.
    Lee, M.
    ANNALS OF SURGICAL ONCOLOGY, 2014, 21 : S74 - S74
  • [48] False-negative rate in the extended prospective TATTOO trial evaluating targeted axillary dissection by carbon tattooing in clinically node-positive breast cancer patients receiving neoadjuvant systemic therapy
    de Boniface, Jana
    Frisell, Jan
    Kuehn, Thorsten
    Wiklander-Brakenhielm, Ingrid
    Dembrower, Karin
    Nyman, Per
    Zouzos, Athanasios
    Gerber, Bernd
    Reimer, Toralf
    Hartmann, Steffi
    BREAST CANCER RESEARCH AND TREATMENT, 2022, 193 (03) : 589 - 595
  • [49] Systematic review of targeted axillary dissection in node-positive breast cancer treated with neoadjuvant systemic therapy: variation in type of marker and timing of placement
    de Wild, Sabine R.
    Koppert, Linetta B.
    van Nijnatten, Thiemo J. A.
    Kooreman, Loes F. S.
    Peeters, Marie-Jeanne T. F. D. Vrancken
    Smidt, Marjolein L.
    Simons, Janine M.
    BRITISH JOURNAL OF SURGERY, 2024, 111 (03)
  • [50] False-negative rate in the extended prospective TATTOO trial evaluating targeted axillary dissection by carbon tattooing in clinically node-positive breast cancer patients receiving neoadjuvant systemic therapy
    Jana de Boniface
    Jan Frisell
    Thorsten Kühn
    Ingrid Wiklander-Bråkenhielm
    Karin Dembrower
    Per Nyman
    Athanasios Zouzos
    Bernd Gerber
    Toralf Reimer
    Steffi Hartmann
    Breast Cancer Research and Treatment, 2022, 193 : 589 - 595
12345